Article
Arachidonate 5-lipoxygenase gene variants affect response to fish oil supplementation by healthy African Americans.
The Journal of nutrition - 1 Aug 2012
Armstrong Patrice, Kelley Darshan S, Newman John W, Staggers Frank E, Hartiala Janna, Allayee Hooman, Stephensen Charles B
Abstract excerpt
Arachidonate 5-lipoxygenase (ALOX5) gene variants that are common in people of African ancestry are associated with a differential cardiovascular disease (CVD) risk that may be ameliorated by intake of (n-3) PUFA, such as EPA or DHA. We conducted a double-masked, placebo (PL)-controlled trial of fish oil (FO) supplements to determine if changes in erythrocyte (n-3) PUFA composition, heart rate, blood pressure,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
